LEADER 01307nam  2200397   450 
001 9910136566003321
005 20180421095405.0
010   $a1-63485-773-9
035   $a(CKB)3710000000907995
035   $a(MiAaPQ)EBC4730651
035   $a(EXLCZ)993710000000907995
100   $a20161110h20162016  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aFDA's expedited drug programs $eanalysis, postmarket monitoring and industry guidance /$fGary Lawrence, editor
210  1$aNew York, [New York] :$cNovinka,$d2016.
210  4$dİ2016
215   $a1 online resource (115 pages) $cillustrations (some color), tables, graphs
225 1 $aDrug Transit and Distribution, Interception and Control
311   $a1-63485-772-0 
320   $aIncludes bibliographical references at the end of each chapters and index.
410  0$aDrug transit and distribution, interception and control.
606   $aDrug monitoring$zUnited States
615  0$aDrug monitoring
676   $a615.7
702   $aLawrence$b Gary
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910136566003321
996   $aFDA's expedited drug programs$92893860
997   $aUNINA